Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis

Rahul Rajeev, MBBS; Kiran K. Turaga, MD


Cancer Control. 2016;23(1):36-46. 

In This Article

Other Surgical Methods

New methods of delivering intraperitoneal chemotherapy, such as early and sequential postoperative intraperitoneal chemotherapy, have been attempted.[73–75] Sequential postoperative intraperitoneal chemotherapy was shown to be inferior in terms of survival outcomes while offering comparable morbidity and mortality rates in a case-control study of patients with CRC, whereas early postoperative intraperitoneal chemotherapy was shown to have a higher rate of complications when given alone or in combination with HIPEC.[73–75] HIPEC is a reliable method for administering intraperitoneal chemotherapy with acceptable complications and survival outcomes.